Detalles de la búsqueda
1.
Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients With Systemic Autoimmune Rheumatic Diseases.
J Rheumatol;
51(3): 305-312, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37839812
2.
Factors Associated With an Electronic Health Record-Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease.
J Rheumatol;
51(5): 529-537, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38428964
3.
Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study.
Rheumatology (Oxford);
2023 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38070152
4.
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave.
Ann Rheum Dis;
81(12): 1742-1749, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35944947
5.
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study.
Ann Rheum Dis;
83(5): 680-682, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38199795
6.
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial.
Lancet Rheumatol;
6(1): e21-e30, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38258675
7.
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines Against COVID-19 Infection Among Patients With Systemic Autoimmune Rheumatic Diseases on Immunomodulatory Medications.
J Rheumatol;
50(5): 697-703, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642428
8.
Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study.
Semin Arthritis Rheum;
63: 152286, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37913612
9.
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study.
Lancet Rheumatol;
5(3): e139-e150, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36844970
10.
Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases.
Sci Transl Med;
15(712): eadf6598, 2023 09 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37672567
11.
Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study.
medRxiv;
2023 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37873462
12.
Validation of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis as the Cause of End-Stage Renal Disease in the US Renal Data System.
ACR Open Rheumatol;
4(1): 8-12, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34643066
13.
Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19.
medRxiv;
2022 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203557
14.
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study.
medRxiv;
2022 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36324801
15.
DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study.
medRxiv;
2022 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35169813
16.
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study.
Semin Arthritis Rheum;
55: 152025, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35617780
17.
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron.
medRxiv;
2022 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35765565
18.
Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy.
RMD Open;
8(1)2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35110366
Resultados
1 -
18
de 18
1
Próxima >
>>